| |
| |
|
| Insider
Information: |
Malik Fady Ibraham |
| Relationship: |
EVP Research & Develop... |
| City: |
South San Francisco |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
135,004 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$7,280,766 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
135,004 |
|
|
| Total
Value |
$7,280,766 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
7
|
|
Stock
price went up :
|
0
|
5
|
| Stock
price went down : |
0
|
2
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
2.5
|
| Percentage
Gain/Loss : |
0.0%
|
 322.1%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Cytokinetics Inc |
CYTK |
EVP Research & Develop... |
2024-06-11 |
135,004 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
120 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 4 of 5
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| CYTK |
Cytokinetics Inc |
EVP Research & Development |
• – – |
2021-01-14 |
4 |
OE |
$9.42 |
$117,750 |
D/D |
12,500 |
162,324 |
0 |
- |
|
| CYTK |
Cytokinetics Inc |
EVP Research & Development |
• – – |
2022-02-28 |
4 |
D |
$35.32 |
$122,137 |
D/D |
(3,458) |
153,004 |
0 |
- |
|
| CYTK |
Cytokinetics Inc |
EVP Research & Development |
• – – |
2021-02-26 |
4 |
D |
$18.73 |
$132,234 |
D/D |
(7,060) |
141,749 |
0 |
- |
|
| CYTK |
Cytokinetics Inc |
EVP Research & Development |
• – – |
2022-05-12 |
4 |
OE |
$9.65 |
$134,975 |
D/D |
13,987 |
182,071 |
0 |
- |
|
| CYTK |
Cytokinetics Inc |
EVP Research & Development |
• • – |
2023-04-13 |
4 |
AS |
$34.21 |
$136,840 |
D/D |
(4,000) |
167,183 |
0 |
% |
|
| CYTK |
Cytokinetics Inc |
EVP Research & Development |
• – – |
2022-04-07 |
4 |
OE |
$6.00 |
$138,888 |
D/D |
23,148 |
191,232 |
0 |
- |
|
| CYTK |
Cytokinetics Inc |
EVP Research & Development |
• • – |
2022-12-08 |
4 |
AS |
$36.28 |
$145,120 |
D/D |
(4,000) |
160,589 |
0 |
% |
|
| CYTK |
Cytokinetics Inc |
SVP Research & Development |
• – – |
2014-12-30 |
4 |
S |
$6.73 |
$145,676 |
D/D |
(21,630) |
3,361 |
0 |
- |
|
| CYTK |
Cytokinetics Inc |
EVP Research & Development |
• – – |
2021-03-08 |
4 |
D |
$19.19 |
$146,496 |
D/D |
(7,634) |
166,348 |
0 |
- |
|
| CYTK |
Cytokinetics Inc |
EVP Research & Development |
• • – |
2022-11-10 |
4 |
AS |
$38.04 |
$152,160 |
D/D |
(4,000) |
164,346 |
0 |
% |
|
| CYTK |
Cytokinetics Inc |
EVP Research & Development |
• • – |
2023-03-09 |
4 |
AS |
$39.10 |
$156,400 |
D/D |
(4,000) |
171,183 |
0 |
% |
|
| CYTK |
Cytokinetics Inc |
EVP Research & Development |
• – – |
2022-03-10 |
4 |
OE |
$6.00 |
$161,112 |
D/D |
26,852 |
194,936 |
0 |
- |
|
| CYTK |
Cytokinetics Inc |
EVP Research & Development |
• • – |
2023-01-12 |
4 |
AS |
$40.47 |
$161,880 |
D/D |
(4,000) |
156,589 |
0 |
% |
|
| CYTK |
Cytokinetics Inc |
EVP Research & Development |
• • – |
2023-02-09 |
4 |
AS |
$43.73 |
$174,920 |
D/D |
(4,000) |
152,589 |
0 |
% |
|
| CYTK |
Cytokinetics Inc |
EVP Research & Development |
• – – |
2021-12-09 |
4 |
OE |
$6.30 |
$183,746 |
D/D |
29,166 |
172,053 |
0 |
- |
|
| CYTK |
Cytokinetics Inc |
EVP Research & Development |
• – – |
2022-03-02 |
4 |
D |
$37.63 |
$188,301 |
D/D |
(5,004) |
148,000 |
0 |
- |
|
| CYTK |
Cytokinetics Inc |
EVP Research & Development |
• • – |
2024-03-05 |
4 |
OE |
$6.67 |
$190,789 |
D/D |
28,604 |
167,577 |
0 |
- |
|
| CYTK |
Cytokinetics Inc |
EVP Research & Development |
• • – |
2024-02-06 |
4 |
OE |
$6.67 |
$190,795 |
D/D |
28,605 |
175,578 |
0 |
- |
|
| CYTK |
Cytokinetics Inc |
EVP Research & Development |
• • – |
2024-04-09 |
4 |
OE |
$6.67 |
$190,795 |
D/D |
28,605 |
171,172 |
0 |
- |
|
| CYTK |
Cytokinetics Inc |
EVP Research & Development |
• • – |
2023-03-06 |
4 |
D |
$39.13 |
$194,007 |
D/D |
(4,958) |
135,183 |
0 |
- |
|
| CYTK |
Cytokinetics Inc |
EVP Research & Development |
• • – |
2022-06-09 |
4 |
OE |
$9.65 |
$207,475 |
D/D |
21,500 |
189,846 |
0 |
- |
|
| CYTK |
Cytokinetics Inc |
EVP Research & Development |
• • – |
2022-07-14 |
4 |
OE |
$9.65 |
$207,475 |
D/D |
21,500 |
189,846 |
0 |
- |
|
| CYTK |
Cytokinetics Inc |
EVP Research & Development |
• • – |
2022-09-08 |
4 |
OE |
$9.65 |
$207,475 |
D/D |
21,500 |
189,846 |
0 |
- |
|
| CYTK |
Cytokinetics Inc |
EVP Research & Development |
• • – |
2022-10-13 |
4 |
OE |
$9.65 |
$207,600 |
D/D |
21,513 |
189,859 |
0 |
- |
|
| CYTK |
Cytokinetics Inc |
EVP Research & Development |
• – – |
2021-01-14 |
4 |
AS |
$19.25 |
$240,619 |
D/D |
(12,500) |
150,441 |
0 |
% |
|
120 Records found
|
|
Page 4 of 5 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
